Human immunodeficiency virus–related morbidity and mortality in injection drug users: Should the AIDS definition be changed yet again?

Epidemiology

Volumn 7, Issue 6, 1996, Pages 563-565

  Royce, Rachel ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE COURSE; ENDOCARDITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PATHOPHYSIOLOGY; SUBSTANCE ABUSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE PROGRESSION; ENDOCARDITIS; HIV INFECTIONS; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0030280676     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta: Centers for Disease Control and Prevention, 1995(no. 2);7.
2. Joint United Nations Programme on HIV/AIDS. The HIV/AIDS Situation in Mid 1996: Global and Regional Highlights. Geneva: UN AIDS Fact Sheet, 1996.
3. Centers for Disease Control and Prevention. Pneumocystis pneumonia: Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-252.
4. Spijkerman IJB, Langendam MW, Veugelers PJ, van Ameijden EJC, Keet IPM, Geskus RB, van den Hoek A, Coutinho RA. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion. Epidemiology 1996;7:571-577.
5. Manoff SB, Vlahov D, Herskowitz A, Solomon L, Muñoz A, Cohn S, Willoughby SB, Nelson KE. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology 1996;7: 566-570.
6. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
7. Mellors J, Rinaldo C Jr, Gupta P, White R, Todd J, Kingsley L. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
8. Royce R, Luckmann R, Fusaro R, Winkelstein W Jr. The natural history of HIV-1 infection: staging classifications of disease. AIDS 1991;5:355-364.
9. Gilks C, Ojoo S, Ojoo J, Brindle R, Paul J, Batchelor B, Kimari J, Newnham R, Bwayo J, Plummer F, Warrell D. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996;347:718-723.
10. van Ameijden E, van den Hoek A, Coutinho R. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994;84:275-281.
11. van den Hoek J, van Haastrecht H, Coutinho R. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989;79:1355-1357.
12. Watters J. Historical perspective on the use of bleach in HIV/AIDS prevention. J Acquir Immun Defic Syndr 1994;7:743-746.
13. Nicolosi A, Correa Leite M, Molinari S, Musicco M, Saracco A, Lazzarin A. Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and Northern Italy, 1986-1990. J Acquir Immun Defic Syndr 1992;5:365-373.
14. Carrel T, Schaffner A, Vogt P, Laske A, Niederhauser U, Schneider J, Turina M. Endocarditis in intravenous drug addicts and HIV infected patients: possibilities and limitations of surgical treatment. J Heart Valve Dis 1993;2:140-147.